Cargando…
Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells
AIMS: Cyclic AMP inhibits vascular smooth muscle cell (VSMC) proliferation which is important in the aetiology of numerous vascular diseases. The anti-mitogenic properties of cAMP in VSMC are dependent on activation of protein kinase A (PKA) and exchange protein activated by cAMP (EPAC), but the mec...
Autores principales: | Kimura, Tomomi E., Duggirala, Aparna, Hindmarch, Charles C.T., Hewer, Richard C., Cui, Mei-Zhen, Newby, Andrew C., Bond, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051994/ https://www.ncbi.nlm.nih.gov/pubmed/24534707 http://dx.doi.org/10.1016/j.yjmcc.2014.02.001 |
Ejemplares similares
-
The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP
por: Kimura, Tomomi E., et al.
Publicado: (2016) -
Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP
por: Smith, Sarah A., et al.
Publicado: (2019) -
cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1
por: Duggirala, Aparna, et al.
Publicado: (2015) -
Dual Role of CREB in The Regulation of VSMC Proliferation: Mode of Activation Determines Pro- or Anti-Mitogenic Function
por: Hudson, Claire, et al.
Publicado: (2018) -
Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells
por: Smith, Madeleine C., et al.
Publicado: (2017)